Overexpression of the antiapoptotic molecule B-cell lymphoma 2 (BCL-2) in B-cell lymphoma/leukemia cells is commonly associated with decreased patient survival [29,30]. The gene discussed is BCL2; the disease is B-cell non-Hodgkin lymphoma.